Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors. Lin AL, Rudneva VA, Richards AL, Zhang Y, et al. Acta Neuropathol 2024;147:85.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lin AL, Rudneva VA, Richards AL, Zhang Y, et al. Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors. Acta Neuropathol 2024;147:85.
PMID: 38758238